Merrimack Pharmaceuticals
MACK
#7933
Rank
NZ$0.37 B
Marketcap
$25.45
Share price
0.00%
Change (1 day)
2.02%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.18

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.19. In 2022 the company made an earnings per share (EPS) of -$0.19 an increase over its 2021 EPS that were of -$0.30.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.18-2.28%
2022-$0.19-38.89%
2021-$0.30-25%
2020-$0.40-81.54%
2019-$2.19-56.95%
2018-$5.08-108.5%
2017$59.74-390.35%
2016-$20.58-7.35%
2015-$22.2165%
2014-$13.46-39.39%
2013-$22.21-54.01%
2012-$48.28-53.71%
2011-$104.3140.37%
2010-$74.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.35-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.41 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.57 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.18 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.49 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA